David Hide Asthma and Allergy Research Centre, Isle of Wight, UK.
Clin Exp Allergy. 2012 Dec;42(12):1697-723. doi: 10.1111/cea.12037.
As in previous years, we felt it would be of value to our readership to summarize the new information provided by the authors who have published in Clinical and Experimental Allergy in 2011 and set this in the context of recent advances in our understanding of the pathogenesis and management of allergic disease in all its many manifestations. In 2011, about 210 articles were published in Clinical and Experimental Allergy including editorials, reviews, opinion articles, guidelines, letters, book reviews and of course at the heart of the journal, papers containing original data. As before, this review is divided into sections based on the way the journal is structured, although this year we have grouped together all the papers dealing with mechanisms of allergic disease, whether they involve patients (clinical mechanisms), pure in vitro studies (basic mechanisms) or animal models (experimental models), as we felt this was a more coherent way to deal with the subject. In the field of asthma and rhinitis, the relationship between airway inflammation and airway dysfunction was of perennial interest to investigators, as were phenotypes and biomarkers. Aspirin hypersensitivity appeared in studies in several papers and there was new interest in asthma in the elderly. The mechanisms involved in allergic disease describe advances in our understanding of T cell responses, the relationship between inflammation and disease, mast cell and basophil activation, steroid resistance and novel therapies. In the section dealing with epidemiology, studies seeking to identify risk factors for allergic disease including vitamin D are prominent, as once again are studies investigating gene-environment interactions. The clinical allergy section focuses on drug allergy, food allergy and immunotherapy. The area of oral immunotherapy for food allergy is well covered and we were grateful to Stephen Durham for guest editing an outstanding special issue on immunotherapy in the centenary year of Leonard Noon's pioneering work. Lastly, in the field of allergens, the interest in component-resolved diagnosis continues to grow and there are also articles describing important novel cultivars and the effect of food processing on the allergenic properties of foods. Another terrific year, full of important and high-quality work,which the journal has been proud to bring to the allergy community.
与往年一样,我们觉得有必要总结一下 2011 年在《临床与实验过敏》上发表的作者提供的新信息,并将其置于我们对过敏疾病发病机制和治疗理解的最新进展的背景下,因为过敏疾病有多种表现形式。2011 年,《临床与实验过敏》发表了大约 210 篇文章,包括社论、综述、观点文章、指南、信件、书评,当然还有期刊的核心部分——含有原始数据的论文。与以往一样,本综述仍然按照期刊的结构进行分类,但今年我们将所有涉及过敏疾病机制的论文集中在一起,无论它们涉及患者(临床机制)、纯体外研究(基础机制)还是动物模型(实验模型),因为我们认为这是处理这一主题的更连贯的方式。在哮喘和鼻炎领域,气道炎症与气道功能障碍之间的关系一直是研究人员关注的焦点,表型和生物标志物也是如此。阿司匹林过敏在几篇论文的研究中出现,老年哮喘也引起了新的兴趣。过敏疾病的发病机制涉及 T 细胞反应、炎症与疾病的关系、肥大细胞和嗜碱性粒细胞的激活、类固醇耐药性和新疗法等方面的进展。在涉及流行病学的部分,包括维生素 D 在内的寻找过敏疾病风险因素的研究引人注目,同样突出的还有研究基因-环境相互作用的论文。临床过敏部分侧重于药物过敏、食物过敏和免疫治疗。食物过敏的口服免疫治疗领域得到了很好的涵盖,我们非常感谢 Stephen Durham 客座编辑了一期在 Leonard Noon 开创性工作百年之际的关于免疫治疗的杰出特刊。最后,在过敏原领域,对成分分辨诊断的兴趣持续增长,还有描述重要新型品种和食品加工对食物过敏原特性影响的文章。又一个非常棒的年份,充满了重要而高质量的工作,期刊为此感到自豪,并将这些工作呈现给过敏社区。